Optimization of Heparin Monitoring with Anti-FXa Assays and the Impact of Dextran Sulfate for Measuring All Drug Activity
Heparins, unfractionated or low molecular weight, are permanently in the spotlight of both clinical indications and laboratory monitoring. An accurate drug dosage is necessary for an efficient and safe therapy. The one-stage kinetic anti-FXa assays are the most widely and universally used with full...
Main Authors: | Jean Amiral, Cédric Amiral, Claire Dunois |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/6/700 |
Similar Items
-
A Novel, Cell-Compatible Hyaluronidase Activity Assay Identifies Dextran Sulfates and Other Sulfated Polymeric Hydrocarbons as Potent Inhibitors for CEMIP
by: Anja Schmaus, et al.
Published: (2025-01-01) -
Effects of the sulfated polysaccharides dextran sulfate and heparin on shrimp immunity and infection by white spot syndrome virus and Vibrio parahaemolyticus
by: Soraat Amphan, et al.
Published: (2025-07-01) -
Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation
by: Wenzhi Wang, et al.
Published: (2016-04-01) -
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
by: Yinglan Pu, et al.
Published: (2017-06-01) -
Novel Isosteviol-Based FXa Inhibitors: Molecular Modeling, In Silico Design and Docking Simulation
by: Marcin Gackowski, et al.
Published: (2023-06-01)